Home >> Report Store >> Healthcare >> Monoclonal Antibody Market Size, Growth, Trends, Industry Report, 2025 >

Monoclonal Antibodies Market, By Source (Murine, Chimeric, Humanized and Human), By Diseases (Autoimmune, Inflammatory, and Infectious), By End User, And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

148 Pages | Published Date : 13 / 07 / 17  | Report Code: AV128 | Report Format: PDF

REPORT HIGHLIGHT

The monoclonal antibody market is estimated to represent a global market of USD 135.6 billion by 2025 with growth rate of 4.8%.

Market Dynamics

Biologics industry has been constantly on rise which strongly support the growth of monoclonal antibody market. Due to this fact, the utilization of monoclonal antibody has increased over the past few years owing to the increased awareness of these therapeutics among physicians and patients. For example, in 2012, approximately 20% of the total pharmaceutical revenue generated from biologic products and is anticipated to increase around 25% by the end of 2018. Furthermore, successful commercialization of monoclonal antibodies like Avastin, Rituxan and Remicade further boosted the customer base. For example, mAbs such as Avastin clocked more than US$ 6 billion of sale across the globe in 2013. Increasing uptake of these therapeutics support the market development.

The market covers the analysis of the commercial or pipeline monoclonal antibody therapeutics such as Humira (adalimumab, anti-TNF), Enbrel, Remicade, Rituxan, Avastin, Herceptin, Lucentis, Erbitux, Eylea and many others.The global market is categorized in terms of source, end use and diseases. Based on source, the market is divided in murine, chimeric, humanized and human. Humanized and human segments are accounted for the largest share of the global market. Reason behind the high growth of this segments as these are considered as a natural drug  and offers good safety on in vivo use.Synagis, Herceptin, Zenapax, Myelotarg, Campath, Xolair, Raptiva, Avastin, Tsyabri, Humira, Vectibix, and Cosentyx are some of the examples of human or humanized monoclonal antibodies.

Disease Takeaway

In terms of diseases, the market is segmented as autoimmune diseases, Inflammatory diseases, Infectious diseases and others.  The utilization of monoclonal antibody therapeutics in cancer treatments and autoimmune diseases is whooping the market growth. Continuous rise in the incidence rate of cancer and autoimmune diseases along with growing demand for effective therapeutics in these area drive the market growth to great extent. End user segment is divided as hospitals, research laboratories and others. Hospitals segment dominated the market, captured almost 41.23% share of the global market in 2016.

Regional Takeaway

Regionally, developed regions such as North America and Europe are considered to be the largest market. Of which, North America accounted for almost 50% share of the global market in 2016. Increasing number of research and development activities coupled with rise in awareness among end users about monoclonal antibody drives the market growth. U.S. based Pfizer, Inc. is currently researching on avelumab—monoclonal antibody for indications such as non-small cell lung cancer, ovarian cancer, and others. These companies spenda significant share of their revenue on research activities, to develop novel mAbs.

Europe is also considered to capture significant market share, 25% global share in 2016. Increasing approval of novel monoclonal antibodies is expected to stimulate the market demand. In 2012, European Medicines Agency (EMA) released guidelines on biosimilar mAb development. This guideline demonstrates the capability of biosimilar mAbs with an interest in development of similar biological mAbs, leading to drive market growth. Asia Pacific and Latin American countries are projected to grow with the promising growth rate during the future period.

Key Vendor Takeaway

Companies such as F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc, Novartis AG; Pfizer; Shanghai Junshi Bioscience Co., Ltd, Daiichi Sankyo Company, Ltd., and others are operating in this market. These companies are engaged in strategic merger and acquisitions to expand their market share in this market. For example, Roche, Inc. acquired California based Genentech which has helped company to expand its market share in monoclonal antibody segment. Aside from Roche, Abbott Laboratories also exhibit strong potential in the monoclonal antibody sector. Growth of this company is attributed to its acquisition of Knoll Pharmaceutical Co. unit and licensing rights to MedImmune’s Synagis and Numax. Further, Johnson & Johnson enhance its market presence supported by the strong growth of Stelara (ustekinumab), Simponi (golimumab), and bapineuzumab.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

  • Historical Year – 2014 & 2015
  • Base Year – 2015
  • Estimated Year – 2016
  • Projected Year – 2025

TARGET AUDIENCE

  • Traders, Distributors, And Suppliers
  • Hospitals
  • Manufacturers
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY SOURCE

  • Murine
  • Chimeric
  • Humanized
  • Human

MARKET, BY DISEASE

  • Autoimmune diseases
  • Inflammatory diseases
  • Infectious diseases
  • others

MARKET, BY END USE

  • Hospitals
  • Research labs
  • Others

MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

MARKET, BY COUNTRY

  • Further Breakdown of The North America Market
    • U.S.
    • Canada
  • Further Breakdown of The Europe Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Market
    • Middle-East and Africa
    • Latin America
TABLE OF CONTENTS

  1. MONOCLONAL ANTIBODIES MARKET OVERVIEW
    • Study Scope
    • Base Year
    • Assumption and Methodology
  2. EXECUTIVE SUMMARY
    • Key Market Facts
    • Geographical Scenario
    • Companies in the Market
  3. MONOCLONAL ANTIBODIES KEY MARKET TRENDS
    • Market Drivers
      • Impact Analysis of Market Drivers
    • Market Restraints
      • Impact Analysis of Market Restraints
    • Market Opportunities
    • Market Future Trends
  4. MONOCLONAL ANTIBODIES INDUSTRY STUDY
    • Company Activity Analysis
    • Regulatory Framework Analysis
    • Pipeline Analysis
    • Value Chain Analysis
  5. MONOCLONAL ANTIBODIES MARKET LANDSCAPE
    • Market Share Analysis
    • Key Innovators
  6. MONOCLONAL ANTIBODIES MARKET – BY SOURCE:
    • Overview
    • Murine
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Chimeric
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Humanized
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Human
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. MONOCLONAL ANTIBODIES MARKET – BY DISEASE:
    • Overview
    • Autoimmune Disease
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Inflammatory Disease
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Infectious Disease
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Others
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. MONOCLONAL ANTIBODIES MARKET – BY END USE:
    • Overview
    • Hospitals
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Research Labs
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
    • Others
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. MONOCLONAL ANTIBODIES MARKET– BY GEOGRAPHY
    • Introduction
    • North America
      • Overview
      • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • S.
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • Canada
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
      • Europe
        • Overview
        • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • France
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Germany
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Rest of Europe
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
        • Asia Pacific (APAC)
          • Overview
          • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • China
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • India
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • Rest of APAC
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
          • Rest of the World
            • Overview
            • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
            • Latin America
              • Overview
              • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
            • Middle East and Africa
              • Overview
              • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
  1. KEY VENDOR ANALYSIS
    • Hoffmann-La Roche Ltd
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • GlaxoSmithKline plc
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Novartis AG
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Pfizer, Inc.
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Shanghai Junshi Bioscience Co., Ltd,
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Daiichi Sankyo Company, Ltd.
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Bristol-Myers Squibb Company
      • Company Overview
      • SWOT Analysis
      • Key Developments
    • Elan
      • Company Overview
      • SWOT Analysis
      • Key Developments
  1. 360 DEGREE ANALYSTVIEW
  2. APPENDIX
    • Research Methodology
    • Abbreviations
    • Disclaimer
    • Contact Us

 

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the monoclonal antibody market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the genitourinary drugs Market by its major segments, which include the source, disease end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • In-depth analysis of the key factors are propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow
RESEARCH METHDOLOGY

AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:

  • Official Company’s Website, Financial and Annual Reporting
  • Government Statistical Data
  • Online Publishing Articles
  • Industry Player’s Investor Presentations
  • Economic News Articles
  • National and International Trade Associations
  • The Financial, Business and Mainstream Press
  • Industry Study Groups and Other Semi-Official Sources
  • Many Other Informative Channels Related to the Market Topics
  • Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.

MARKET FORECAST

Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario. 

MARKET ANALYSIS

Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy And Reliablity

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

 

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

 

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This